SynOx Therapeutics
Developer of humanized monoclonal antibodies intended to significantly improve the lives of people living with Tenosynovial giant cell tumors (TGCT) and other colony-stimulating factor 1 (CSF-1) and m...
Valuation
$0
Share Price
N/A
Total Raised
$170.6M
Last Round
N/A